» Articles » PMID: 38704390

RNA-sequencing Suggests Extracellular Matrix and Vasculature Dysregulation Could Impair Neurogenesis in Schizophrenia Cases with Elevated Inflammation

Overview
Date 2024 May 4
PMID 38704390
Authors
Affiliations
Soon will be listed here.
Abstract

A subgroup of schizophrenia cases with elevated inflammation have reduced neurogenesis markers and increased macrophage density in the human subependymal zone (SEZ; also termed subventricular zone or SVZ) neurogenic niche. Inflammation can impair neurogenesis; however, it is unclear which other pathways are associated with reduced neurogenesis. This research aimed to discover transcriptomic differences between inflammatory subgroups of schizophrenia in the SEZ. Total RNA sequencing was performed on SEZ tissue from schizophrenia cases, designated into low inflammation (n = 13) and high inflammation (n = 14) subgroups, based on cluster analysis of inflammation marker gene expression. 718 genes were differentially expressed in high compared to low inflammation schizophrenia (FDR p < 0.05) and were most significantly over-represented in the pathway 'Hepatic Fibrosis/Hepatic Stellate-Cell Activation'. Genes in this pathway relate to extracellular matrix stability (including ten collagens) and vascular remodelling suggesting increased angiogenesis. Collagen-IV, a key element of the basement membrane and fractones, had elevated gene expression. Immunohistochemistry revealed novel collagen-IV+ fractone bulbs within the human SEZ hypocellular gap. Considering the extracellular matrix's regulatory role in SEZ neurogenesis, fibrosis-related alterations in high inflammation schizophrenia may disrupt neurogenesis. Increased angiogenesis could facilitate immune cell transmigration, potentially explaining elevated macrophages in high inflammation schizophrenia. This discovery-driven analysis sheds light on how inflammation may contribute to schizophrenia neuropathology in the neurogenic niche.

Citing Articles

Role of Glial Cells and Receptors in Schizophrenia Pathogenesis.

Tizabi Y, Antonelli M, Tizabi D, Aschner M Neurochem Res. 2025; 50(2):85.

PMID: 39869278 DOI: 10.1007/s11064-025-04336-8.


Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment.

Cao Y, Liang J, Dai B, Shan F, Xia Q BMC Psychiatry. 2024; 24(1):961.

PMID: 39741241 PMC: 11687148. DOI: 10.1186/s12888-024-06437-0.

References
1.
Zhang Y, Catts V, Sheedy D, McCrossin T, Kril J, Weickert C . Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl Psychiatry. 2016; 6(12):e982. PMC: 5290336. DOI: 10.1038/tp.2016.238. View

2.
Puvogel S, Alsema A, North H, Webster M, Weickert C, Eggen B . Single-Nucleus RNA-Seq Characterizes the Cell Types Along the Neuronal Lineage in the Adult Human Subependymal Zone and Reveals Reduced Oligodendrocyte Progenitor Abundance with Age. eNeuro. 2024; 11(3). PMC: 10913050. DOI: 10.1523/ENEURO.0246-23.2024. View

3.
North H, Weissleder C, Fullerton J, Sager R, Webster M, Weickert C . A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone. Transl Psychiatry. 2021; 11(1):635. PMC: 8674325. DOI: 10.1038/s41398-021-01742-8. View

4.
Miller B, Buckley P, Seabolt W, Mellor A, Kirkpatrick B . Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011; 70(7):663-71. PMC: 4071300. DOI: 10.1016/j.biopsych.2011.04.013. View

5.
Kerever A, Arikawa-Hirasawa E . Optimal Extracellular Matrix Niches for Neurogenesis: Identifying Glycosaminoglycan Chain Composition in the Subventricular Neurogenic Zone. Front Neuroanat. 2021; 15:764458. PMC: 8520954. DOI: 10.3389/fnana.2021.764458. View